Glaukos upgraded to overweight by Piper Sandler ahead of product launches (GKOS)


Ophthalmologist examining patient

FG Trade/iStock via Getty Images

Glaukos Corp. (NYSE:GKOS) has been upgraded by Piper Sandler to overweight due to upcoming launches for its iStent Infinite and iDose products.

Calling the launches “amongst the most exciting in Midcap Medtech,” Piper said it believes the Street is underestimating the ramp

Source link

Leave A Reply

Your email address will not be published.